The European Network of Centres in Pharmacoepidemiology and Pharmacovigilance (ENCePP) will hold its virtual annual plenary meeting on 18 November 2021.
Registration is open to ENCePP Partners (centres and networks) until 26 October 2021.
Objectives of the meeting:
-
To learn about key results from observational studies on Covid-19, methodological challenges that remain to be addressed, and how ENCePP could further promote best practice for Covid-19 research;
-
To present the recently finalised CHMP Guideline on registry-based studies;
-
To update on the work programme of the HMA-EMA Big Data Task Force and discuss the interface with ENCePP activities. Topics for discussion include the creation of curricula in Data Science, Pharmacoepidemiology and Biostatistics, the upgrading of the EU PAS Register and ENCePP Resources Database, an update on the Real-World Interrogation Network in the European Union (DARWIN EU) and the pilots for data analytics with EMA committees;
-
To discuss the result of the surveys and agree on the amendments needed for the metadata and functionalities of the EU PAS Register and ENCePP Resources Database;
-
To exchange views on the activities of the ENCePP Steering Group and Working Groups (WGs), the renewal of the WGs, and the proposed new ENCePP activities (e.g. new SIGs).
The event is for ENCePP Partners only, registration from other individuals will not be accepted.
The WebEx joining instructions will be sent to those ENCePP members who have registered via the below linked form.
Related information: Draft agenda | Registration form
Details
- Publication date
- 13 October 2021
- Author
- European Medicines Agency